Combined effect of cosolvent and cyclodextrin on solubilization of nonpolar drugs

Journal of Pharmaceutical Sciences

Volumn 88, Issue 11, 1999, Pages 1107-1111

  Li, Ping ^a   Zhao, Luwei ^a   Yalkowsky, Samuel H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALCOHOL; CYCLODEXTRIN; DRUG SOLVENT; FLUASTERONE; PRASTERONE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; LIGAND BINDING; MATHEMATICAL MODEL; SOLUBILIZATION; STOICHIOMETRY;

EID: 0032742298     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js990159d     Document Type: Article

References (21)

1. Martin, A., et al. Physical Pharmacy, 4th ed.; Lea & Febiger: Philadelphia, PA, 1993.
2. Yalkowsky, S. H. Solubility and Solubilization in Aqueous Media; American Chemical Society: Washington, DC, 1999; in press.
3. Sweetana, S.; Akers, M. J. Solubility principles and practices for parenteral drug dosage form development. PDA J. Pharm. Sci. Technol. 1996, 50, 330-342.
4. Loftsson, T.; Brewster, M. Pharmaceutical applications of cyclodextrins. 1. solubilization and stabalization. J. Pharm. Sci. 1996, 85, 1017-1025.
5. Uekama, K. Pharmaceutical applications of cyclodextrin complexations. Yukugaku Zusshi. 1981, 101, 857-873.
6. Connors, K. A. The stability of cyclodextrin complex in solution. Chem. Rev. 1997, 1325-1357.
7. Yalkowsky, S. H. et al. Formulation-related problems associated with intraveneous drug delivery. J. Pharm. Sci. 1998, 87, 787-795.
8. Rubino, J. T. Solubilization of some poorly soluble drugs by cosolvents. Ph.D. Dissertation, The University of Arizona, 1984.
9. Rajewski, R. A.; Stella, A. J. Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery. J. Pharm. Sci. 1966, 85, 1142-1168.
10. Loftsson, T. et al. Cyclodextrin complexation of NSAIDs: physicochemical characteristics. Eur. J. Pharm. Sci. 1993, 1, 95-101.
11. Pitha, J.; Hoshino, T. Effect of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orange. Int. J. Pharm. 1992, 80, 243-251.
12. Kelloff, G. J. et. al. New agents for cancer chemoprevention. J. Cell. Biochem. 1996, 265, 1-28.
13. Reer, O.; Muller, B. W. Investigation of the influence of cosolvents and surfactants on the complexation of dexamethasone with hydroxypropyl-β-cyclodextrin by use of a simplex lattice design. Eur. J. Pharm. Biopharm. 1993, 39, 105-111.
14. Zung, J. B. et al. Influence of alcohol addition on the γ-CD: pyrene complex. J. Phys. Chem. 1991, 95, 6701-6709.
15. Kano, K. et al. Fluorescence quenching of pyrene and naphthalene in aqueous cyclodextrin solutions. Evidence of three-component complex formation. J. Phys. Chem. 1982, 86, 1833-1838.
16. Hamai, S. Inclusion compounds in the systems of β-cyclodextrin-alcohol-pyrene in aqueous solution. J. Phys. Chem. 1989, 93, 2074-2078.
17. Li, A.; Yalkowsky, S. H. Solubility of organic solutes in ethanol/water mixtures. J. Pharm. Sci. 1994, 83, 1735-1740.
18. Harrison J. C.; Eftnk, M. R. Cyclodextrin-adamantanecarboxylate inclusion complexes: a model system for the hydrophobic effect. Biopolymers 1982, 21, 1153-1166.
19. Li, P.; Tabibi, S. E.; Yalkowsky, S. H. Combined effect of complexation and pH on solubilization. J. Pharm. Sci. 1998, 87, 1535-1537.
20. Tachibana, M.; Kiba, N. Correlation between inclusion formation constant and distribution coefficient in a liquid -liquid extraction sysytem consisting of hydrocarbon solvents and aqueous dimethyl sulfoxide solutions of β-cyclodextrin. Analyst 1997, 122, 903-909.
21. Munoz de la Pena et al. Alcohol size as a factor in the ternary complexes formed with pyrene and β-cyclodextrin. J. Am. Chem. Soc. 1991, 113, 1572-1578.